1. Home
  2. CVE vs NTRA Comparison

CVE vs NTRA Comparison

Compare CVE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVE
  • NTRA
  • Stock Information
  • Founded
  • CVE 2009
  • NTRA 2003
  • Country
  • CVE Canada
  • NTRA United States
  • Employees
  • CVE N/A
  • NTRA N/A
  • Industry
  • CVE Oil & Gas Production
  • NTRA Medical Specialities
  • Sector
  • CVE Energy
  • NTRA Health Care
  • Exchange
  • CVE Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • CVE 24.1B
  • NTRA 20.9B
  • IPO Year
  • CVE N/A
  • NTRA 2015
  • Fundamental
  • Price
  • CVE $13.18
  • NTRA $157.73
  • Analyst Decision
  • CVE Strong Buy
  • NTRA Strong Buy
  • Analyst Count
  • CVE 4
  • NTRA 17
  • Target Price
  • CVE $25.75
  • NTRA $183.00
  • AVG Volume (30 Days)
  • CVE 13.2M
  • NTRA 1.5M
  • Earning Date
  • CVE 05-08-2025
  • NTRA 05-08-2025
  • Dividend Yield
  • CVE 3.97%
  • NTRA N/A
  • EPS Growth
  • CVE N/A
  • NTRA N/A
  • EPS
  • CVE 1.05
  • NTRA N/A
  • Revenue
  • CVE $37,926,044,442.00
  • NTRA $1,831,000,000.00
  • Revenue This Year
  • CVE N/A
  • NTRA $18.39
  • Revenue Next Year
  • CVE N/A
  • NTRA $16.72
  • P/E Ratio
  • CVE $12.27
  • NTRA N/A
  • Revenue Growth
  • CVE 2.85
  • NTRA 51.50
  • 52 Week Low
  • CVE $10.23
  • NTRA $92.14
  • 52 Week High
  • CVE $21.08
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • CVE 51.63
  • NTRA 54.99
  • Support Level
  • CVE $12.88
  • NTRA $149.77
  • Resistance Level
  • CVE $13.83
  • NTRA $165.91
  • Average True Range (ATR)
  • CVE 0.38
  • NTRA 4.89
  • MACD
  • CVE -0.01
  • NTRA 0.35
  • Stochastic Oscillator
  • CVE 24.18
  • NTRA 55.18

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: